Peer Review History
| Original SubmissionSeptember 4, 2019 |
|---|
|
PONE-D-19-24860 Effective treatments for the inactivation of Francisella tularensis PLOS ONE Dear Dr. Uda, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Nov 12 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Paulo Lee Ho, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript entitled “effective treatments for the inactivation of Francisella tularensis” by Azaki et al. is extremely straight forward, easy to follow, and for the most part well written. I would require several edits and clarifications prior to publication: 1. Consider changing title to “Effective methods for the inactivation of Francisella tularensis” 2. Abstract line 34. Change to read “…ultraviolet radiation compared to suspensions…” and change throughout manuscript, irradiation is the act of exposing to radiation, whereas ultraviolet light is a form of radiation. 3. Abstract line 37. What is meant by “conventional conditions required”? This sentence is confusing to the reviewer because most of the processes described in the manuscript would be considered quite conventional. 4. Page 3 line 44. The statement regarding LAI in the United States prior to 1978 is misleading. This is true particularly in context of the first sentence of the introduction. While I do not disagree that human error is the primary reason for LAI, the data provided prior to 1978, largely did not include engineering controls such as biosafety cabinets and respiratory protection. Please consider revising this first paragraph for clarity. 5. Page 3 line 50. Change to read “…have not been clearly identified…” 6. Page 4. General comment. To make your work more applicable to international standards, I would also briefly discuss the BMBL –Biosafety in Microbiological and Biomedical Laboratories Guide. This document is used to govern most or all US labs. Additionally, the goal of this paper is to demonstrate the validation of inactivation of Tier one select agents, this is now required by US law. This law is briefly described and referenced in Chua et al. https://wwwnc.cdc.gov/eid/article/25/5/18-0928_article. This paper should also be cited in the current manuscript as it discusses the use of formaldehyde for inactivating F. tularensis. 7. Page 5 line 104. Change to read “Therefore, the present study aimed to confirm….” 8. Page 12 and applicable to throughout the manuscript, consider making a statement in the method section (if it is there and I missed it, I apologize) that all FBS was used at 10% final concentration (if that is the case). 9. Page 13. Line 242, change “resistance of sterilization” to “effectiveness of filter sterilization” 10. Page 10 line 248 and Page 20 Line 368. While I do not disagree that 70% ethanol is effective, I do disagree that 70% ethanol is “the most effective”. 11. Page 16 line 306. Change “had failed” to “was not achieved” 12. Page 17 line 322. Change to read “…bacteria were found…” as bacteria is plural. 13. Page 18 line 338. This first sentence warrants a reference being cited, perhaps a review article. 14. Page 20. Starting on line 375. The authors should postulate why the addition of the FBS hindered inactivation but CDM did not. A publication (Omotade et al. J Applied Microbio https://doi.org/10.1111/jam.12644) could be cited and discussed because although this work uses B. anthracis spores it does discuss UV interference for bacterial inactivation, even in the presence of minimal compounds. 15. Page 20 and 21. Lines 308-399. I believe these details are important but the strain origins and characteristics would be better presented in a table format. 16. Page 21. Line 406. I would recommend the authors make a statement indicating that this work should be used as a guide and each laboratory should validate these procedures in their own laboratory. This would be in accordance with current US Law but also would provide appropriate perspective of the data reported here. 17. Page 27 line 579. Change “stood” to “maintained” 18. Figures and throughout. The term “untreatment” is not commonly used, I would change to “control” or “no treatment” Reviewer #2: Review of PONE-D-19-24860 Effective Treatments for the Inactivation of Francisella tularensis This manuscript is a well-written summary of experiments designed to determine the inactivation efficacy of numerous approaches for Francisella tularensis. The data are useful to laboratorians working with this organism and will improve biosafety procedures within BSL-3 laboratories. Specific Comments: Line 34 – missing word in sentence. “…highly resistant to ultraviolet irradiation than suspensions…” Suggest changing to “…highly resistant to ultraviolet irradiation, more so than suspensions…” Line 41-42 – reference for this statement (human error is leading cause) is needed Line 68 – no change needed, but the BMBL is an additional and excellent reference to take note of https://www.aaalac.org/accreditation/RefResources/BMBL.pdf Line 94-103 – Calfee and Wendling (Science of the Total Environment, 2013) is another reference for previously studied inactivation methods for Ft. This study may be worth including as a reference for further background on non-suspension-type inactivation studies. https://www.ncbi.nlm.nih.gov/pubmed/23208274 Line 110 – “CDM” first use, please define Line 124 – “FBS” first use, please define Line 142 – please add/indicate the filter media type (PES, MCE, etc.) and the supplier part number Line 152-153 – Statement is confusing, check for accuracy. “After measuring the CFU in the supernatant and pellets, the samples were serially diluted and cultured…” were viable cells (CFU determination) determined for pellets and supers separately? Then combined and determined? Please add clarification. Line 177 – Please replace the ‘ in 1/4’ with actual units. Please use metric units when possible. Line 196 – please indicate filter type and part# Line 248 – suggest deletion of first sentence in this paragraph. “most effective agent” is subjective. Effectiveness depends on many factors (surface type contaminated, biological agent, temperature, humidity, organic load, etc.), therefore one ‘agent’ cannot simply be labeled the ‘most effective’ for all situations. It may be the most ‘common’ disinfectant in laboratories, but one could argue that iodine or sodium hypochlorite are superior disinfectants. Line 301- First sentence of this paragraph is written as though the mechanism of inactivation was determined in this study (thymine dimer generation), however, this is not the case. Suggest deleting this first sentence, or rewording to indicate that UV light is reported to inactivate bacterial cells via thymine dimer formation, and provide reference. Line 330 – Here and throughout, filters are described no differently as chemical and physical inactivation methods. However, filtration is a physical removal/separation mechanism, and likely inactivates very few organisms. Suggest adding some text to clarify this difference here, and potentially other areas in the manuscript where filtration is mentioned. Line 333 – mention of “complete inactivation”, see comment above about filtration and inactivation versus separation Line 368 – see previous comment about ethanol as the ‘most effective’ technique to inactivate non-spore-forming bacteria Line 403 – Suggest revision of sentence suggesting “our data should be useful to confirm whether samples are inactivated”. I suggest that your data is useful to develop effective inactivation procedures, however you data cannot be used to confirm others’ inactivation procedures success. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Effective methods for the inactivation of Francisella tularensis PONE-D-19-24860R1 Dear Dr. Uda, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Paulo Lee Ho, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: much improved manuscript and thanks to the authors for addressing my comments from the original review**** Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-19-24860R1 Effective methods for the inactivation of Francisella tularensis Dear Dr. Uda: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Paulo Lee Ho Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .